EditorialKommentar
Predicting Liver-Related Outcomes in Steatotic Liver Disease
JAMA · 16.04.2024 · 331 (15) · 1274
DOI: 10.1001/jama.2024.0799 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA, erschienen am 16.04.2024. Verfasst von Zobair M Younossi. Beteiligte Einrichtung: The Global NASH Council, Washington, DC. Hauptthemen laut MEDLINE: Liver, Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
LiverNon-alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2HumansAbdomenPrognosisLiver CirrhosisElasticity Imaging TechniquesBiopsyLiver NeoplasmsCarcinoma, HepatocellularLiver FailureLiver TransplantationRisk Factors
Autor:innen und Institutionen
- The Global NASH Council, Washington, DC.
- Beatty Center for Liver and Obesity Research, Inova Health System, Falls Church, Virginia.
- Center for Outcomes Research in Liver Disease, Washington, DC.
Zitieren
APA
Younossi, Z. M. (2024). Predicting Liver-Related Outcomes in Steatotic Liver Disease. JAMA, 331(15), 1274. https://doi.org/10.1001/jama.2024.0799
Vancouver
Younossi ZM. Predicting Liver-Related Outcomes in Steatotic Liver Disease. JAMA. 2024;331(15):1274. doi:10.1001/jama.2024.0799
BibTeX
@article{Younossi2024,
author = {Younossi, Zobair M},
title = {Predicting Liver-Related Outcomes in Steatotic Liver Disease},
journal = {JAMA},
year = {2024},
volume = {331},
number = {15},
pages = {1274},
doi = {10.1001/jama.2024.0799}
}
EUVIMED